G - Physics – 01 – N
Patent
G - Physics
01
N
G01N 33/574 (2006.01) C12N 15/10 (2006.01) C12Q 1/68 (2006.01)
Patent
CA 2706881
Methods of using TLE3 as a marker for predicting the likelihood that a patient's cancer will respond to chemotherapy. Methods of using TLE3 as a marker for selecting a chemotherapy for a cancer
La présente invention concerne des procédés d'utilisation de TLE3 comme marqueur pour prédire la probabilité qu'a le cancer d'un patient de répondre à une chimiothérapie. L'invention concerne également des procédés d'utilisation de TLE3 (transducin-like enhancer of split 3) comme marqueur pour sélectionner une chimiothérapie pour un cancer.
Beck Rodney A.
Ring Brian Z.
Ross Douglas T.
Seitz Robert S.
Applied Genomics Inc.
Kirby Eades Gale Baker
LandOfFree
Tle3 as a marker for chemotherapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tle3 as a marker for chemotherapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tle3 as a marker for chemotherapy will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2072607